{"log_id": 1350252609410972936, "direction": 0, "words_result_num": 33, "words_result": [{"probability": {"variance": 4e-06, "average": 0.997589, "min": 0.994797}, "location": {"width": 127, "top": 329, "height": 29, "left": 245}, "words": "【儿童用药】"}, {"probability": {"variance": 5e-06, "average": 0.998003, "min": 0.992963}, "location": {"width": 263, "top": 362, "height": 32, "left": 304}, "words": "尚无儿童使用本品的经验"}, {"probability": {"variance": 4e-06, "average": 0.997426, "min": 0.99371}, "location": {"width": 130, "top": 435, "height": 30, "left": 243}, "words": "【老年用药】"}, {"probability": {"variance": 1e-05, "average": 0.997821, "min": 0.990126}, "location": {"width": 184, "top": 469, "height": 29, "left": 305}, "words": "参见【用法用量】"}, {"probability": {"variance": 8e-06, "average": 0.997618, "min": 0.991481}, "location": {"width": 178, "top": 538, "height": 30, "left": 244}, "words": "【药物相互作用】"}, {"probability": {"variance": 0.000955, "average": 0.993077, "min": 0.824208}, "location": {"width": 729, "top": 565, "height": 39, "left": 304}, "words": "本品与其他有降压作用的药物,包括抗高血压药物如利尿剂、β一阻滞"}, {"probability": {"variance": 1.8e-05, "average": 0.998374, "min": 0.981424}, "location": {"width": 666, "top": 594, "height": 41, "left": 237}, "words": "剂或血管紧张素转化酶抑制剂合用,可能产生附加的降压的作用"}, {"probability": {"variance": 0.021146, "average": 0.954058, "min": 0.389627}, "location": {"width": 404, "top": 632, "height": 37, "left": 308}, "words": "与咪替丁合用可增加本品的血药浓度"}, {"probability": {"variance": 0.009141, "average": 0.967873, "min": 0.538262}, "location": {"width": 622, "top": 665, "height": 38, "left": 306}, "words": "拉西地平与白蛋白和α-1-糖蛋白高度结合(结合率>95%)"}, {"probability": {"variance": 1.2e-05, "average": 0.9981, "min": 0.984147}, "location": {"width": 724, "top": 700, "height": 37, "left": 309}, "words": "拉西地平与常用抗高血压药物如β一阻滞剂、利尿剂合用,或与地高"}, {"probability": {"variance": 0.009721, "average": 0.969921, "min": 0.527738}, "location": {"width": 523, "top": 730, "height": 40, "left": 239}, "words": "辛、甲苯磺丁脲或华法林合用时,无特殊相互作用"}, {"probability": {"variance": 3.9e-05, "average": 0.996933, "min": 0.97142}, "location": {"width": 723, "top": 763, "height": 39, "left": 310}, "words": "与其他二氢吡啶相似,拉西地平不能与葡萄柚汁同服,因其生物利用"}, {"probability": {"variance": 0, "average": 0.999778, "min": 0.999579}, "location": {"width": 96, "top": 806, "height": 27, "left": 239}, "words": "度会改变"}, {"probability": {"variance": 3.7e-05, "average": 0.997297, "min": 0.966627}, "location": {"width": 725, "top": 828, "height": 38, "left": 309}, "words": "对于服用环孢素的肾移植患者,临床试验表明,拉西地平可逆转由环"}, {"probability": {"variance": 0, "average": 0.999675, "min": 0.998505}, "location": {"width": 475, "top": 860, "height": 38, "left": 238}, "words": "孢素引起的肾血浆流量及肾小球滤过率的减少"}, {"probability": {"variance": 1.1e-05, "average": 0.997245, "min": 0.988676}, "location": {"width": 712, "top": 893, "height": 36, "left": 323}, "words": "已知拉西地平可通过细胞色素CYP3A4代谢,因此,合用CYP3A4抑"}, {"probability": {"variance": 2e-06, "average": 0.998888, "min": 0.993825}, "location": {"width": 485, "top": 923, "height": 40, "left": 240}, "words": "制剂和诱导剂可能会影响拉西地平的代谢和清除"}, {"probability": {"variance": 2.2e-05, "average": 0.995727, "min": 0.987544}, "location": {"width": 136, "top": 1006, "height": 35, "left": 245}, "words": "【药物过量】"}, {"probability": {"variance": 2e-06, "average": 0.998313, "min": 0.995909}, "location": {"width": 267, "top": 1040, "height": 34, "left": 309}, "words": "尚无服用本品过量的病例"}, {"probability": {"variance": 0.011482, "average": 0.976777, "min": 0.410667}, "location": {"width": 730, "top": 1063, "height": 48, "left": 308}, "words": "服用本品过量最可能发生的问题是外周血管舒张过度低血压和心"}, {"probability": {"variance": 1e-06, "average": 0.999041, "min": 0.995484}, "location": {"width": 594, "top": 1098, "height": 42, "left": 241}, "words": "动过速。理论上,可能发生心动过缓或房室传导时间延长"}, {"probability": {"variance": 0.003272, "average": 0.987486, "min": 0.679916}, "location": {"width": 726, "top": 1131, "height": 41, "left": 310}, "words": "无特殊解毒方法,通用标准措施为监测心功能,给予适当的变持和治"}, {"probability": {"variance": 0, "average": 0.999561, "min": 0.999065}, "location": {"width": 75, "top": 1174, "height": 27, "left": 241}, "words": "疗措施"}, {"probability": {"variance": 4e-06, "average": 0.998345, "min": 0.99541}, "location": {"width": 129, "top": 1240, "height": 30, "left": 250}, "words": "【药理毒理】"}, {"probability": {"variance": 0.000177, "average": 0.996462, "min": 0.926232}, "location": {"width": 728, "top": 1266, "height": 39, "left": 311}, "words": "拉西地平为特异性高效钙离子拮抗剂,对于血管平滑肌的钙通道具有"}, {"probability": {"variance": 1e-06, "average": 0.998619, "min": 0.997095}, "location": {"width": 119, "top": 1306, "height": 28, "left": 245}, "words": "高度选择性"}, {"probability": {"variance": 1e-06, "average": 0.999284, "min": 0.996798}, "location": {"width": 641, "top": 1330, "height": 39, "left": 313}, "words": "其主要作用为扩张外周小动脉,减少外周血管阻力和降低血压"}, {"probability": {"variance": 0.003115, "average": 0.987189, "min": 0.678243}, "location": {"width": 703, "top": 1367, "height": 38, "left": 313}, "words": "健康志愿者口口服4mg的拉西地平后,可观察到QTc间隔的轻度延长"}, {"probability": {"variance": 0.000943, "average": 0.990312, "min": 0.83122}, "location": {"width": 729, "top": 1395, "height": 38, "left": 309}, "words": "在为期四年的随机、双盲ELSA临床研究(欧洲拉西地平用于动脉粥"}, {"probability": {"variance": 7.2e-05, "average": 0.997154, "min": 0.954373}, "location": {"width": 771, "top": 1425, "height": 39, "left": 244}, "words": "样硬化临床研究)中,动脉硬化症的主要疗效指标是超声检查颈动脉内膜"}, {"probability": {"variance": 0.002068, "average": 0.989078, "min": 0.729596}, "location": {"width": 794, "top": 1453, "height": 42, "left": 245}, "words": "中膜厚度(IMT)。与抗动脉粥样硬化作用效果一致,服用乐息平的患者的"}, {"probability": {"variance": 0.000558, "average": 0.987464, "min": 0.921858}, "location": {"width": 192, "top": 1494, "height": 27, "left": 247}, "words": "IMT值有明显改善"}, {"probability": {"variance": 1e-06, "average": 0.999285, "min": 0.997469}, "location": {"width": 154, "top": 1560, "height": 29, "left": 253}, "words": "【药代动力学】"}], "language": 3}